Dr. Fumiko Chino talks with Dr. Evan Garrad, the first author of the JCO OP manuscript, " Artificial Intelligence Among US Hematology-Oncology Fellows: A Multicenter Survey of Education, Attitudes, and Clinical Use ," which was simultaneously published with his oral presentation at ASCO 2026. LINK TO FULL TRANSCRIPT
Dr. Chino welcomes Dr. Christopher Manz, a medical oncologist at Dana-Farber Cancer Institute, to discuss new research highlighting care gaps for those receiving care while in prison. Dr. Manz investigates cancer care delivery and payment policy and how they contribute to disparities in cancer outcomes, and is the first author of the manuscript, " Cancer Screening, Diagnosis and Treatment for Vulnerable Patients Incarcerated in United States Prisons " which is featured in JCO OP's May print issu...
Dr. Chino welcomes Dr. Timothy Pawlik and patient advocate Joey Tan discuss new research highlighting national data regarding cannabis use in cancer survivors. Dr. Pawlik is the senior author of the manuscript, " Patterns of Cannabis Use Among Cancer Survivors: Insights From the Behavioral Risk Factor Surveillance System " which is featured in JCO OP's April print issue. LINK TO FULL TRANSCRIPT...
Dr. Chino welcomes Dr. Jennifer Miller and breast cancer survivor Megan-Claire Chase to discuss Dr. Miller's recent OP article, " Representation of Women, Older Adults, and Racial and Ethnic Minoritized Patients in Pivotal Trials for U.S. Food and Drug Administration Novel Oncology Therapeutic Approvals, 2012-2021: Bright Spot Trials and Trends Over Time ," highlighting new research about how we are doing with diversity in key cancer clinical trials TRANSCRIPT Dr. Fumiko Chino: Hello and welcome...
Dr. Chino welcomes Hari Raman, MD, MBA, author of " End-of-Life Care for Older Adults With Blood Cancers With Medicare Advantage Versus Medicare Fee-For-Service Insurance ," to discuss new research highlighting how insurance type may affect receipt of quality end-of-life care for patients with blood cancers. TRANSCRIPT Dr. Fumiko Chino: Hello, and welcome to Put into Practice , the podcast for the JCO Oncology Practice . I am Dr. Fumiko Chino, an associate professor in radiation oncology at MD A...
Dr. Chino welcomes Dr. Erika Moen and Dr. Dan Zuckerman to discuss new research highlighting how specialist scarcity is felt by oncologists practicing in rural environments. Dr. Moen is the first author on " Rural Oncologists' Perceptions of Specialty Scarcity and Repercussions for Care Delivery: A Qualitative Study, " which is featured in JCO OP's January 2026 issue. TRANSCRIPT Dr. Fumiko Chino: Hello, and welcome to Put Into Practice , the podcast for the JCO Oncology Practice . I'm Dr. Fumiko...
Dr. Chino talks with Dr. Talya Salz, the first author of the JCO OP manuscript " Impact of an Electronic Patient-Reported Outcome–Informed Clinical Decision Support Tool on Clinical Discussions With Head and Neck Cancer Survivors: Findings From the HN-STAR Randomized Controlled Trial (WF-1805CD) " which was published earlier this year simultaneous to the ASCO Quality Care Symposium. Jeff White, the Director of PR and Strategic Communications for the American Society for Radiation Oncology, also ...
Dr. Chino talks with Dr. Navneet Majhail and patient advocate Laurie Adami about CAR-T therapy, an advance cancer treatment that biologically engineers a patient's own T-cells to recognize and kill cancer cells. This discussion will be based off the JCO OP article, " Outpatient Administration of Chimeric Antigen Receptor T-Cell Therapy Using Remote Patient Monitoring ," on which Dr. Majhail served as lead author. TRANSCRIPT Dr. Fumiko Chino: Hello, and welcome to Put into Practice , the podcast ...
Dr. Chino welcomes Dr. Vivek Patel and Dr. Eleonora Teplinsky to discuss a recent article in JCO OP that reported a podcast-based curriculum could improve knowledge and comfort with common education topics for oncology fellows. TRANSCRIPT Dr. Fumiko Chino: Hello, and welcome to Put Into Practice , the podcast for JCO Oncology Practice . I am Dr. Fumiko Chino, an assistant professor in Radiation Oncology at MD Anderson Cancer Center with a research focus on access, affordability, and equity. Ther...
Dr. Chino welcomes Dr. Yael Schenker to discuss a new clinical trial testing the best way of engaging patients with Advance Care Planning (ACP), the process of understanding personal values, life goals, and medical care preferences so that patient wishes are honored at end-of-life. TRANSCRIPT Dr. Fumiko Chino: Hello, and welcome to Put Into Practice , the podcast for the JCO Oncology Practice . I am Dr. Fumiko Chino, an Associate Professor in Radiation Oncology at MD Anderson Cancer Center with ...
Dr. Chino welcomes Dr. Emily Mackler, PharmD, BCOP, the Co-founder and Chief Medical Officer of the YesRx program and an Adjunct Clinical Associate Professor at the University of Michigan. The YesRx program has saved patients in Michigan more than 17 million dollars in the past 2 years. Dr. Mackler's article, " Transforming Cancer Drug Access: Insights Into Utilization and Clinician Satisfaction in a Statewide Cancer Drug Repository Network ," presented at the ASCO Quality Care Symposium. TRANSC...
Germline genetic testing can play an essential role in identifying cancer risk, guiding treatment decisions, and informing screening and/or preventive strategies for both patients and patient family members. Access to timely and convenient genetic testing can be challenging based on increased indications for testing, larger gene panels, and high numbers of positive tests which are overloading a limited genetics workforce. This is leading to long wait times and widening disparities in access to g...
An estimated 85k adolescents and young adults (AYAs) between the ages of 15 to 39 will be diagnosed with cancer in the United States this year. AYAs with advanced cancer face care gaps for psychosocial support and communication. A recent paper published in JCO OP titled " Promoting Resilience in Stress Management: A Randomized Controlled Trial of a Novel Psychosocial Intervention for Adolescents and Young Adults With Advanced Cancer " detailed the findings of a clinical trial testing a skills-ba...
There is often a disconnect in toxicity assessment between what is reported on clinical trials as being "well tolerated" and the lived experience of taking a treatment for patients. Toxicity minimizing language including "safe" and "tolerable" are subjective and can downplay quality of life limiting side effects from treatment. A recent paper published in JCO OP reported that less than half of phase 3 clinical trials had "complete" toxicity reporting including total adverse events, deaths, and d...
Frustrations regarding the costs and difficulties with parking at hospitals is a common concern voiced by patients, families, and healthcare providers. Transportation barriers to receiving cancer care are incredibly common despite what appears to be relatively straightforward solutions. Dr. Chino welcomes two patient-centered health policy experts to discuss this: Dr. Arjun Gupta, MBBS, an Assistant Professor at the University of Minnesota; and Dr. Shakira Grant, MBBS, MSCR, the Founder & CE...
Dr. Chino talks with Dr. Erin Roesch and patient advocate Julia Maues about pregnancy associated cancer with a focus on breast cancer, the most common cancer diagnosed during pregnancy. This discussion is based off an JCO OP review article published in late 2024 called "Multidisciplinary Management of Pregnancy-Associated Breast Cancer." Transcript Dr. Fumiko Chino:Hello and welcome to Put Into Practice , the podcast for the JCO Oncology Practice . I'm Dr. Fumiko Chino, an assistant professor in...
Dr. Chino talks with Dr. Atif Khan and Dr. Lola Fayanju about the shift in breast cancer management from reducing locoregional recurrence and improving breast cancer mortality to deintensification, shared decision making, and improved quality of life. This discussion will be based off a JCO OP editorial published in late 2024 called "Contextual Framework for Understanding Treatment De-Escalation in Patients With Breast Cancer." Transcript Dr. Fumiko Chino: Hello, and welcome to Put into Practice...
Dr. Chino discusses the past, present, and future of prior authorization in cancer care with Dr. Michael Anne Kyle, a health policy expert with a research focus on utilization management and patient burdens from prior auth. TRANSCRIPT Dr. Fumiko Chino: Hello and welcome to Put Into Practice , the podcast for the JCO Oncology Practice . I'm Dr. Fumiko Chino, an Assistant Professor in Radiation Oncology at MD Anderson Cancer Center with a research focus on access, affordability and equity. On toda...
Dr. Fumiko Chino talks with Dr. Aditi Singh and patient advocate Liz Salmi about how this essential tool for documentation could be optimized to be more patient-centered. This discussion will be based off the JCO OP article published in late 2024, " Re-Envisioning the Electronic Health Records to Optimize Patient-Centered Cancer Care, Quality, Surveillance, and Research ," on which Dr. Singh served as the lead author. TRANSCRIPT Dr. Fumiko Chino: Hello and welcome to Put into Practice , the podc...
Host Dr. Fumiko Chino sits down with co-editor and health outcomes researcher Dr. Ryan Nipp, and contributing author Dr. Kelly Shanahan who is living with metastatic breast cancer to have a candid conversation about financial toxicity, the lived experience for patients, and what we can do to move the needle on affordability in cancer care. TRANSCRIPT The disclosures for guests on this podcast can be found in the show notes. Dr. Fumiko Chino: Hello and welcome to the inaugural episode of Put into...
Dr. Pennell and Dr. James Hammock discuss the provision of oncologic services by Project Access safety net care coordination programs. NATHAN PENNELL: Hello, and welcome to the latest JCO Oncology Practice podcast, brought to you by the ASCO Podcast Network, a collection of nine programs covering a range of educational and scientific content, and offering enriching insight into the world of cancer care. You can find all recordings, including this one, at podcast.asco.org. My name is Dr. Nate Pen...
Dr. Pennell and Dr. Friedman discuss the variety of ethical dilemmas for health care providers brought on by COVID-19. NATE PENNELL: Hello, and welcome to the latest JCO Oncology Practice Podcast, brought to you by the ASCO Podcast Network, a collection of nine programs covering a range of educational and scientific content, and offering enriching insight into the world of cancer care. You can find all recordings, including this one, at podcast.asco.org My name is Dr. Nate Pennell, Medical Oncol...
Dr. Pennell and Dr. Jennifer Tsui discuss the processes that lead to suboptimal EOL care within Medicaid populations and among racial/ethnic minority groups. Hello, and welcome to the latest JCO Oncology Practice podcast, brought to you by the ASCO Podcast Network, a collection of nine programs covering a range of educational and scientific content and offering enriching insight into the world of cancer care. You can find all recordings, including this one, at podcast.asco.org. My name is Dr. Na...
Dr. Pennell and Dr. Jan Franko discuss Dr. Franko's article, "Effect of surgical oncologist turnover on hospital volume and treatment outcomes among patients with upper gastrointestinal malignancies" Hello, and welcome to the latest JCO Oncology Practice podcast, brought to you by the ASCO Podcast Network, a collection of nine programs covering a range of educational and scientific content and offering enriching insight into the world of cancer care. You can find all recordings, including this o...
Dr. Pennell, Dr. Khosa and Dr. Marshall discuss the recent JCO OP publication, "Gender Differences in Faculty Rank and Leadership Positions Among Hematologists and Oncologists in the United States" Welcome to the latest JCO Oncology Practice podcast, brought to you by the ASCO podcast network, a collection of nine programs covering a range of educational and scientific content, and offering enriching insight into the world of cancer care. You can find all recordings, including this one, at podca...
Dr. Pennell talks with Dr. Daniel Richardson discuss physician burnout and the author's curriculum designed to mitigate burnout and foster solidarity among fellows. Support for JCO Oncology Practice podcasts is provided in part by AstraZeneca, dedicated to advancing options and providing hope for people living with cancer. More information at AstraZeneca-US.com. Hello, and welcome to the latest JCO Oncology Practice podcast, brought to you by the ASCO Podcast Network, a collection of nine progra...
Dr. Pennell and Dr. Lisa Lowenstein discuss decision coaching in the LDCT setting and how it provides an opportunity for patients to confirm their screening decision by ensuring they are truly informed. Hello and welcome to the latest JCO Oncology Practice podcast, brought to you by the ASCO Podcast Network, a collection of nine programs, covering a range of educational and scientific content, and offering enriching insight into the world of cancer care. You can find all recordings, including th...
Dr. Nathan Pennell, Dr. Muhammed Beg and Ms. Erin Williams discuss improving the time-to-activation of new clinical trials at an NCI-Designated Comprehensive Cancer Center. Read the article: https://ascopubs.org/doi/full/10.1200/OP.19.00325 TRANSCRIPT [PIANO MUSIC PLAYING] DR. PENNELL: Welcome to the latest Journal of Oncology Practice podcast brought to you by the ASCO Podcast Network, a collection of nine programs covering a range of educational and scientific content and offering enriching in...
Dr. Nate Pennell talks with Dr. Joel Segel about "Coverage, Financial Burden, and the Affordable Care Act for Cancer Patients." Article available online at Journal of Oncology Practice . TRANSCRIPT Support for Journal of Oncology Practice podcasts is provided in part by AstraZeneca, dedicated to advancing options and providing hope for people living with cancer. More information at astrazeneca.us.com. [MUSIC PLAYING] Welcome to the latest Journal of Oncology Practice podcast, brought to you by t...
Dr. Nate Pennell discusses "How to Know if a Somatic Tumor Mutation is Targetable" with Suanna Bruinooge, the director of research, strategy, and operations at ASCO's Center for Research and Analytics, or CENTRA, and Dr. Richard Schilsky, senior vice president and chief medical officer at ASCO. Read the related article "Determining If a Somatic Tumor Mutation Is Targetable and Options for Accessing Targeted Therapies." [DR. NATHAN PENNELL] Welcome to the latest Journal of Oncology Practice Podca...
